Holen Sie sich die Stockscreener-App
52.50
0.04%
0.02
Handel nachbörslich:
52.51
0.010
+0.02%
Schlusskurs vom Vortag:
$52.48
Offen:
$53
24-Stunden-Volumen:
261.93K
Relative Volume:
0.56
Marktkapitalisierung:
$2.90B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$23.68M
KGV:
1,050.00
EPS:
0.05
Netto-Cashflow:
$108.67M
1W Leistung:
+2.30%
1M Leistung:
-0.89%
6M Leistung:
-13.18%
1J Leistung:
+17.00%
1-Tages-Spanne:
$52.10
$53.34
1-Wochen-Bereich:
$50.49
$53.34
52-Wochen-Spanne:
$42.75
$64.47
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
52.50 | 2.90B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova PLC's (NASDAQ:LIVN) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? - Simply Wall St
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
Quantbot Technologies LP Buys New Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC's (NASDAQ:LIVN) Stock Has Shown A Decent Performance: Have Financials A Role To Play? - Yahoo Finance
Wall Street Analysts Predict a 37.2% Upside in LivaNova (LIVN): Here's What You Should Know - Yahoo Finance
Implantable Cardioverter Defibrillator Market Size, Trends, - openPR
Perfusion Systems Market Size, Trends, Growth, Opportunities - openPR
Needham retains Buy on Livanova shares, cites impressive track record - Investing.com
Needham & Company LLC Reiterates "Buy" Rating for LivaNova (NASDAQ:LIVN) - MarketBeat
Algert Global LLC Purchases 47,008 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Segall Bryant & Hamill LLC Invests $2.13 Million in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova's SWOT analysis: sleep apnea platform potential drives stock outlook - Investing.com
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Primecap Management Co. CA - MarketBeat
Principal Financial Group Inc. Has $9.01 Million Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Cornercap Investment Counsel Inc. Sells 10,684 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Position Boosted by Victory Capital Management Inc. - MarketBeat
10,067 Shares in LivaNova PLC (NASDAQ:LIVN) Acquired by Entropy Technologies LP - MarketBeat
LivaNova (NASDAQ:LIVN) Cut to "Buy" at StockNews.com - MarketBeat
State of New Jersey Common Pension Fund D Purchases 11,782 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences - sharewise
Medical Implants Market Is Booming Worldwide 2024-2031 | Biotronik, Inc., Livanova Plc, NuVasive - openPR
LivaNova's (LIVN) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
LivaNova PLC (LIVN) SEC Filing Summary - Quartzy
Shareholders Will Be Pleased With The Quality of LivaNova's (NASDAQ:LIVN) Earnings - Yahoo Finance
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St
Vagus Nerve Stimulation (VNS) Market Market Size, Trends, - openPR
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints - TipRanks
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - sharewise
LivaNova reports positive results in sleep apnea trial By Investing.com - Investing.com South Africa
LivaNova reports positive results in sleep apnea trial - Investing.com India
LivaNova plc (LIVN) Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - StreetInsider.com
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
LivaNova (NASDAQ:LIVN) Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
LivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
How Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2% - Yahoo Finance
Chest Drainage Catheters Market Driven by Advancements in Medical Devices | LivaNova PLC, Mediplus, - EIN News
Oversold Conditions For LivaNova (LIVN) - Nasdaq
LivaNova (NASDAQ:LIVN) Trading Down 3.9%Should You Sell? - MarketBeat
LivaNova Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Nisa Investment Advisors LLC Lowers Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Is a LivaNova PLC (LIVN) Promising Medical Stock with Growth Potential? - Insider Monkey
Emerald Advisers LLC Purchases 14,302 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Simply Wall St
Earnings Beat: LivaNova PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Where are the Opportunities in (LIVN) - Stock Traders Daily
abrdn plc Purchases 70,618 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova maintains VNS Therapy classification By Investing.com - Investing.com Australia
LivaNova maintains VNS Therapy classification - Investing.com India
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):